Corton Capital’s Gilead Sciences GILD Stock Holding History

Corton Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,340	Closed	-$277K	–	465
2023 Q1	$277K	Buy	+3,340	New	+$277K	0.19%	167

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's GILD Position: Q2 2023 in Review

Corton Capital sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 3,340 shares — an estimated $277K sold.

Corton Capital first reported a position in GILD in Q1 2023 and held it in 1 quarter. The position peaked at $277K in Q1 2023. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Corton Capital reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
Corton Capital sold 3,340 Gilead Sciences shares in Q2 2023, an estimated $277K.
Corton Capital first reported a position in Gilead Sciences in Q1 2023 and held it in 1 quarter.
Corton Capital's Gilead Sciences position peaked at $277K in Q1 2023.
1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Corton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.